Christian Glennie
Stock Analyst at Stifel Nicolaus
(2.73)
# 2,908
Out of 4,792 analysts
77
Total ratings
37.2%
Success rate
2.9%
Average return
Main Sectors:
Stocks Rated by Christian Glennie
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: CTEC Convatec Group PLC | Reiterated: Buy | 315p | 221p | +42.53% | 11 | Aug 4, 2026 | |
| AIM: AMS Advanced Medical Solutions Group plc | Reiterated: Buy | 245p | 281p | -12.66% | 12 | May 21, 2026 | |
| AIM: DXRX Diaceutics PLC | Reiterated: Buy | 225p | 155p | +45.16% | 10 | Sep 23, 2025 | |
| AIM: EKF EKF Diagnostics Holdings plc | Reiterated: Buy | 29p → 35p | 25p | +37.80% | 5 | Sep 16, 2025 | |
| LON: GNS Genus plc | Reiterated: Hold | 1,850p → 2,300p | 2,234p | n/a | 7 | Sep 9, 2025 | |
| LON: HIK Hikma Pharmaceuticals PLC | Reiterated: Buy | 2,650p | 1,535p | n/a | 8 | Apr 24, 2025 | |
| INDV Indivior Pharmaceuticals | Reiterated: Buy | $15 | $34.77 | n/a | 4 | Apr 24, 2025 | |
| AMS: PHARM Pharming Group N.V. | Reiterated: Buy | n/a | $0.951 | n/a | 4 | Jun 4, 2024 | |
| AIM: AVCT Avacta Group Plc | Reiterated: Buy | 105p | 71p | n/a | 3 | May 23, 2024 | |
| BME: PHM Pharma Mar, S.A. | Downgraded: Hold | €109.00 | €78.65 | n/a | 1 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 4,441p → 4,071p | 5p | n/a | 3 | Jul 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 7,031p → 5,551p | 48p | n/a | 2 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 15,394p → 13,914p | 67p | n/a | 4 | Jun 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 12,952p | 0.12p | n/a | 3 | May 18, 2017 |
Convatec Group PLC
Aug 4, 2026
Reiterated: Buy
Price Target: 315p
Current: 221p
Upside: +42.53%
Advanced Medical Solutions Group plc
May 21, 2026
Reiterated: Buy
Price Target: 245p
Current: 281p
Upside: -12.66%
Diaceutics PLC
Sep 23, 2025
Reiterated: Buy
Price Target: 225p
Current: 155p
Upside: +45.16%
EKF Diagnostics Holdings plc
Sep 16, 2025
Reiterated: Buy
Price Target: 29p → 35p
Current: 25p
Upside: +37.80%
Genus plc
Sep 9, 2025
Reiterated: Hold
Price Target: 1,850p → 2,300p
Current: 2,234p
Upside: n/a
Hikma Pharmaceuticals PLC
Apr 24, 2025
Reiterated: Buy
Price Target: 2,650p
Current: 1,535p
Upside: n/a
Indivior Pharmaceuticals
Apr 24, 2025
Reiterated: Buy
Price Target: $15
Current: $34.77
Upside: n/a
Pharming Group N.V.
Jun 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.951
Upside: n/a
Avacta Group Plc
May 23, 2024
Reiterated: Buy
Price Target: 105p
Current: 71p
Upside: n/a
Pharma Mar, S.A.
Nov 11, 2020
Downgraded: Hold
Price Target: €109.00
Current: €78.65
Upside: n/a
Jul 25, 2018
Reiterated: Buy
Price Target: 4,441p → 4,071p
Current: 5p
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: 7,031p → 5,551p
Current: 48p
Upside: n/a
Jun 8, 2017
Reiterated: Buy
Price Target: 15,394p → 13,914p
Current: 67p
Upside: n/a
May 18, 2017
Reiterated: Buy
Price Target: 12,952p
Current: 0.12p
Upside: n/a